Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 20 de 104
Filter
1.
Issues in Educational Research ; 32(4):1567-1583, 2022.
Article in English | ProQuest Central | ID: covidwho-20241615

ABSTRACT

Thesis writing is an endeavour that many undergraduate students have to surmount coupled with its inevitable challenges. Consequently, this study was conducted to investigate the diverse thesis writing challenges experienced by arts and humanities students enrolled in Bachelor of Arts degrees in Communication, English Language, and Filipino Language in a state university in the northern part of Luzon, Philippines. A descriptive phenomenology was utilised via focus group discussions to collect data. Through thematic analysis, three main themes or facets of the diverse challenges in thesis writing have been identified. The facets are (1) student-emanating;(2) adviser-emanating;and (3) pandemic/emergency remote teaching-emanating. This research adds to the literature on the challenges in undergraduate thesis writing during emergency remote teaching, provides an input towards pedagogical implications, and recommends future research directions.

2.
Child Obes ; 2022 Jul 19.
Article in English | MEDLINE | ID: covidwho-20233086

ABSTRACT

Background: Societal changes during the COVID-19 pandemic may affect children's health behaviors and exacerbate disparities. This study aimed to describe children's health behaviors during the COVID-19 pandemic, how they vary by sociodemographic characteristics, and the extent to which parent coping strategies mitigate the impact of pandemic-related financial strain on these behaviors. Methods: This study used pooled data from 50 cohorts in the Environmental influences on Child Health Outcomes Program. Children or parent proxies reported sociodemographic characteristics, health behaviors, and parent coping strategies. Results: Of 3315 children aged 3-17 years, 49% were female and 57% were non-Hispanic white. Children of parents who reported food access as a source of stress were 35% less likely to engage in a higher level of physical activity. Children of parents who changed their work schedule to care for their children had 82 fewer min/day of screen time and 13 more min/day of sleep compared with children of parents who maintained their schedule. Parents changing their work schedule were also associated with a 31% lower odds of the child consuming sugar-sweetened beverages. Conclusions: Parents experiencing pandemic-related financial strain may need additional support to promote healthy behaviors. Understanding how changes in parent work schedules support shorter screen time and longer sleep duration can inform future interventions.

3.
Curr Rheumatol Rep ; 2023 Jun 10.
Article in English | MEDLINE | ID: covidwho-20238558

ABSTRACT

PURPOSE OF REVIEW: Individuals with post-acute sequelae of SARS-CoV-2 (PASC) complain of persistent musculoskeletal pain. Determining how COVID-19 infection produces persistent pain would be valuable for the development of therapeutics aimed at alleviating these symptoms. RECENT FINDINGS: To generate hypotheses regarding neuroimmune interactions in PASC, we used a ligand-receptor interactome to make predictions about how ligands from PBMCs in individuals with COVID-19 communicate with dorsal root ganglia (DRG) neurons to induce persistent pain. In a structured literature review of -omics COVID-19 studies, we identified ligands capable of binding to receptors on DRG neurons, which stimulate signaling pathways including immune cell activation and chemotaxis, the complement system, and type I interferon signaling. The most consistent finding across immune cell types was an upregulation of genes encoding the alarmins S100A8/9 and MHC-I. This ligand-receptor interactome, from our hypothesis-generating literature review, can be used to guide future research surrounding mechanisms of PASC-induced pain.

4.
Open Forum Infect Dis ; 10(5): ofad168, 2023 May.
Article in English | MEDLINE | ID: covidwho-2322657

ABSTRACT

Background: We compared postinfection severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) neutralizing antibody (nAb) responses among children and adults while the D614G-like strain and Alpha, Iota, and Delta variants circulated. Methods: During August 2020-October 2021, households with adults and children were enrolled and followed in Utah, New York City, and Maryland. Participants collected weekly respiratory swabs that were tested for SARS-CoV-2 and had sera collected during enrollment and follow-up. Sera were tested for SARS-CoV-2 nAb by pseudovirus assay. Postinfection titers were characterized with biexponential decay models. Results: Eighty participants had SARS-CoV-2 infection during the study (47 with D614G-like virus, 17 with B.1.1.7, and 8 each with B.1.617.2 and B.1.526 virus). Homologous nAb geometric mean titers (GMTs) trended higher in adults (GMT = 2320) versus children 0-4 (GMT = 425, P = .33) and 5-17 years (GMT = 396, P = .31) at 1-5 weeks postinfection but were similar from 6 weeks. Timing of peak titers was similar by age. Results were consistent when participants with self-reported infection before enrollment were included (n = 178). Conclusions: The SARS-CoV-2 nAb titers differed in children compared to adults early after infection but were similar by 6 weeks postinfection. If postvaccination nAb kinetics have similar trends, vaccine immunobridging studies may need to compare nAb responses in adults and children 6 weeks or more after vaccination.

5.
Indian Journal of Occupational and Environmental Medicine ; 27(1):100, 2023.
Article in English | EMBASE | ID: covidwho-2315796

ABSTRACT

Introduction: Long COVID is a term coined for long term post COVID-19 disease complications. Touted as the 'pandemic after the pandemic' it has significant implications for employment especially on productivity and quality of worker output. Objective(s): 1. To assess the baseline knowledge among employees working in selected smart phone manufacturing companies regarding COVID-19 disease, COVID vaccination and long COVID complications. 2. To assess the prevalence of long COVID complications among the study subjects. Methodology: We followed a quantitative cross-sectional study design between May-Jun 2022 in 6 factories across South India. A semi-structured, face-validated interview schedule was administered to the employees via Google Forms. Data was analyzed using SPSS v.21. Result(s): A total of 118 employees were included in the study. Most employees were male (89.2%), between 25-30 years of age (46.3%) and had completed their Bachelor's degree (71.29%). Most had at least 1-5 years of current work experience (80.5%). Almost 55.1% of the employees had suffered from COVID-19 in the past of which 33.8% had been hospitalised. Only 42.8% of employees knew about long COVID complications and 33.1% knew of only one symptom. None of the employees had taken the booster dose of the vaccine despite 67.8% knowing that the vaccine protected against severe disease. Almost 75% of employees reported to suffer from one or more post COVID complications. Long standing fatigue (16.9%), cough and breathing difficulty (6.1%) were the most common complaints. Conclusion and recommendations: Low awareness regarding long COVID will impact health seeking behavior and increase presenteeism at the workplace. Increasing awareness regarding COVID-19 disease, vaccinations and the post COVID complications through training programmes and health education sessions will bridge the key knowledge gaps identified. Promotion of booster dose vaccination against COVID-19 for all employees will help in reducing the burden of long COVID at the workplace.

6.
Eur J Dev Res ; : 1-22, 2023 Apr 29.
Article in English | MEDLINE | ID: covidwho-2312265

ABSTRACT

We examine the association between the Covid-19 pandemic and and access to basic needs, and how households respond using various coping strategies in the context of Nigeria. We use data from the Covid-19 National Longitudinal Phone Surveys (Covid-19 NLPS-2020) conducted during the Covid-19 lockdown. Our findings reveal that the Covid-19 pandemic is associated with households' exposure to shocks such as illness or injury, disruption of farming, job losses, non-farm business closure, and increase in price of food items and farming inputs. These negative shocks have severe consequences on access to basic needs of households, and the outcomes are heterogeneous across gender of household head and rural-urban residence. Households adopt a number of coping strategies, both formal and informal to mitigate the effects of the shocks on access to basic needs. The findings of this paper lend credence to the growing evidence on need to support households exposed to negative shocks and the role of formal coping mechanisms for households in developing countries.


Nous examinons le lien entre les chocs provoqués par la Covid-19 et l'accès aux services répondant aux besoins fondamentaux, et la façon dont les ménages ont réagi en utilisant diverses stratégies d'adaptation au Nigeria. Nous utilisons les données d'enquêtes téléphoniques longitudinales nationales Covid-19 (Covid-19 NLPS-2020) menées pendant le confinement lié à la Covid-19. Nos résultats révèlent que la pandémie de Covid-19 est associée à l'exposition des ménages à des chocs tels que la maladie ou les blessures, la perturbation de l'agriculture, les pertes d'emplois, la fermeture d'entreprises non agricoles et l'augmentation des prix des denrées alimentaires et des intrants agricoles. Ces chocs négatifs affectent gravement l'accès aux besoins fondamentaux des ménages, et les résultats sont hétérogènes selon le sexe des chefs de famille et selon le lieu de résidence rural ou urbain des ménages. Les ménages adoptent diverses stratégies d'adaptation formelles et informelles pour atténuer les effets des chocs sur l'accès aux besoins fondamentaux. Les conclusions de ce document donnent du crédit aux preuves de plus en plus nombreuses de la nécessité de soutenir les ménages exposés aux chocs négatifs et du rôle des mécanismes d'adaptation formels pour les ménages dans les pays en développement.

7.
2nd International Conference on Next Generation Intelligent Systems, ICNGIS 2022 ; 2022.
Article in English | Scopus | ID: covidwho-2305257

ABSTRACT

The year 2020 was an unprecedented time for all, combating COVID, following precautionary measures and finding a cure for the virus was of utmost importance. As the COVID-19 is here to stay, it is imperative to detect it as early as possible. Our web application (COVID RayScan) is a prediction-based Machine Learning application which can be used by technicians, doctors at hospitals to understand a X-ray or CT-Scan and hence quickly detect if a patient suffers from Covid or not. According to NCBI, it takes 17.4 minutes for a doctor to treat every patient and that metric has increased exponentially with increase in COVID. COVID RayScan with the help of Deep Learning CNN Networks like ResNet50,VGG16,Inception and Xception helps a technician to run the X-Ray/CT-Scan image through our web application to get the desired result which in turn saves the doctor's as well as patients time and make the process much more efficient. © 2022 IEEE.

8.
Materials Horizons: From Nature to Nanomaterials ; : 33-49, 2023.
Article in English | Scopus | ID: covidwho-2297297

ABSTRACT

Nanotechnology has various applications in dentistry. Nanomaterials are being widely researched to detect and diagnose oral diseases such as oral cancer, dental caries, periodontal disease, halitosis, salivary biomarkers of many systemic conditions such as COVID-19, diabetes, etc. Nanomaterials that find use in this area include metal/metal oxide nanoparticles (carriers or agents for MRI and ultrasound images), carbon nanotubes (diagnosis in DNA transformation biomarker for changes in protein structure), nanocore shells (contrast imaging for tumours), 1D, 2D nanostructures (scanning, detector for protein diseases, detection of DNA mutation, diagnosis of gene mutation), and quantum dots (diagnosis of gene and protein structures due to optical properties, detection of tumour, and lymph nodes). Specific characteristics of nanomaterials are utilized to increase the sensitivity and aid in the early detection of oral conditions. This chapter discusses the roles of various nanomaterials for the detection of oral cancer and premalignant lesions, molecular imaging of oral cancer, detection of oral biofilm, the role of nanosensors for identification of pathogenic bacteria, early diagnosis of periodontal disease, photoacoustic imaging of periodontium, nanobiosensors for salivary biomarker detection, detection of oral malodor, and viral infections. © 2023, The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd.

9.
JAMA Netw Open ; 6(4): e2310696, 2023 04 03.
Article in English | MEDLINE | ID: covidwho-2299841

ABSTRACT

Importance: Limited data exist on pediatric health care utilization during the COVID-19 pandemic among children and young adults born preterm. Objective: To investigate differences in health care use related to COVID-19 concerns during the pandemic among children and young adults born preterm vs those born at term. Design, Setting, and Participants: In this cohort study, questionnaires regarding COVID-19 and health care utilization were completed by 1691 mother-offspring pairs from 42 pediatric cohorts in the National Institutes of Health Environmental Influences on Child Health Outcomes Program. Children and young adults (ages 1-18 years) in these analyses were born between 2003 and 2021. Data were recorded by the August 31, 2021, data-lock date and were analyzed between October 2021 and October 2022. Exposures: Premature birth (<37 weeks' gestation). Main Outcomes and Measures: The main outcome was health care utilization related to COVID-19 concerns (hospitalization, in-person clinic or emergency department visit, phone or telehealth evaluations). Individuals born preterm vs term (≥37 weeks' gestation) and differences among preterm subgroups of individuals (<28 weeks', 28-36 weeks' vs ≥37 weeks' gestation) were assessed. Generalized estimating equations assessed population odds for health care used and related symptoms, controlling for maternal age, education, and psychiatric disorder; offspring history of bronchopulmonary dysplasia (BPD) or asthma; and timing and age at COVID-19 questionnaire completion. Results: Data from 1691 children and young adults were analyzed; among 270 individuals born preterm, the mean (SD) age at survey completion was 8.8 (4.4) years, 151 (55.9%) were male, and 193 (71.5%) had a history of BPD or asthma diagnosis. Among 1421 comparison individuals with term birth, the mean (SD) age at survey completion was 8.4 (2.4) years, 749 (52.7%) were male, and 233 (16.4%) had a history of BPD or asthma. Preterm subgroups included 159 individuals (58.5%) born at less than 28 weeks' gestation. In adjusted analyses, individuals born preterm had a significantly higher odds of health care utilization related to COVID-19 concerns (adjusted odds ratio [aOR], 1.70; 95% CI, 1.21-2.38) compared with term-born individuals; similar differences were also seen for the subgroup of individuals born at less than 28 weeks' gestation (aOR, 2.15; 95% CI, 1.40-3.29). Maternal history of a psychiatric disorder was a significant covariate associated with health care utilization for all individuals (aOR, 1.44; 95% CI, 1.17-1.78). Conclusions and Relevance: These findings suggest that during the COVID-19 pandemic, children and young adults born preterm were more likely to have used health care related to COVID-19 concerns compared with their term-born peers, independent of a history of BPD or asthma. Further exploration of factors associated with COVID-19-related health care use may facilitate refinement of care models.


Subject(s)
Asthma , Bronchopulmonary Dysplasia , COVID-19 , Infant, Newborn , Pregnancy , Female , Young Adult , Humans , Male , Child , Infant , Child, Preschool , Adolescent , Infant, Premature , Cohort Studies , Pandemics , COVID-19/epidemiology , Asthma/epidemiology , Asthma/therapy , Delivery of Health Care , Patient Acceptance of Health Care
10.
J Exp Med ; 220(5)2023 05 01.
Article in English | MEDLINE | ID: covidwho-2260121

ABSTRACT

X-linked recessive deficiency of TLR7, a MyD88- and IRAK-4-dependent endosomal ssRNA sensor, impairs SARS-CoV-2 recognition and type I IFN production in plasmacytoid dendritic cells (pDCs), thereby underlying hypoxemic COVID-19 pneumonia with high penetrance. We report 22 unvaccinated patients with autosomal recessive MyD88 or IRAK-4 deficiency infected with SARS-CoV-2 (mean age: 10.9 yr; 2 mo to 24 yr), originating from 17 kindreds from eight countries on three continents. 16 patients were hospitalized: six with moderate, four with severe, and six with critical pneumonia, one of whom died. The risk of hypoxemic pneumonia increased with age. The risk of invasive mechanical ventilation was also much greater than in age-matched controls from the general population (OR: 74.7, 95% CI: 26.8-207.8, P < 0.001). The patients' susceptibility to SARS-CoV-2 can be attributed to impaired TLR7-dependent type I IFN production by pDCs, which do not sense SARS-CoV-2 correctly. Patients with inherited MyD88 or IRAK-4 deficiency were long thought to be selectively vulnerable to pyogenic bacteria, but also have a high risk of hypoxemic COVID-19 pneumonia.


Subject(s)
COVID-19 , Myeloid Differentiation Factor 88 , Child , Humans , Adaptor Proteins, Signal Transducing , COVID-19/complications , Myeloid Differentiation Factor 88/genetics , SARS-CoV-2 , Toll-Like Receptor 7
11.
ACS omega ; 8(6):5349-5360, 2023.
Article in English | Europe PMC | ID: covidwho-2238893

ABSTRACT

The human Betacoronavirus SARS-CoV-2 is a novel pathogen claiming millions of lives and causing a global pandemic that has disrupted international healthcare systems, economies, and communities. The virus is fast mutating and presenting more infectious but less lethal versions. Currently, some small-molecule therapeutics have received FDA emergency use authorization for the treatment of COVID-19, including Lagevrio (molnupiravir) and Paxlovid (nirmaltrevir/ritonavir), which target the RNA-dependent RNA polymerase and the 3CLpro main protease, respectively. Proteins downstream in the viral replication process, specifically the nonstructural proteins (Nsps1–16), are potential drug targets due to their crucial functions. Of these Nsps, Nsp4 is a particularly promising drug target due to its involvement in the SARS-CoV viral replication and double-membrane vesicle formation (mediated via interaction with Nsp3). Given the degree of sequence conservation of these two Nsps across the Betacoronavirus clade, their protein–protein interactions and functions are likely to be conserved as well in SARS-CoV-2. Through AlphaFold2 and its recent advancements, protein structures were generated of Nsp3 and 4 lumenal loops of interest. Then, using a combination of molecular docking suites and an existing library of lead-like compounds, we virtually screened 7 million ligands to identify five putative ligand inhibitors of Nsp4, which could present an alternative pharmaceutical approach against SARS-CoV-2. These ligands exhibit promising lead-like properties (ideal molecular weight and log P profiles), maintain fixed-Nsp4-ligand complexes in molecular dynamics (MD) simulations, and tightly associate with Nsp4 via hydrophobic interactions. Additionally, alternative peptide inhibitors based on Nsp3 were designed and shown in MD simulations to provide a highly stable binding to the Nsp4 protein. Finally, these therapeutics were attached to dendrimer structures to promote their multivalent binding with Nsp4, especially its large flexible luminal loop (Nsp4LLL). The therapeutics tested in this study represent many different approaches for targeting large flexible protein structures, especially those localized to the ER. This study is the first work targeting the membrane rearrangement system of viruses and will serve as a potential avenue for treating viruses with similar replicative function.

12.
Transp Res Interdiscip Perspect ; 17: 100750, 2023 Jan.
Article in English | MEDLINE | ID: covidwho-2245331

ABSTRACT

[This corrects the article DOI: 10.1016/j.trip.2022.100575.].

13.
N Engl J Med ; 388(7): 621-634, 2023 02 16.
Article in English | MEDLINE | ID: covidwho-2243580

ABSTRACT

BACKGROUND: Safe and effective vaccines against coronavirus disease 2019 (Covid-19) are urgently needed in young children. METHODS: We conducted a phase 1 dose-finding study and are conducting an ongoing phase 2-3 safety, immunogenicity, and efficacy trial of the BNT162b2 vaccine in healthy children 6 months to 11 years of age. We present results for children 6 months to less than 2 years of age and those 2 to 4 years of age through the data-cutoff dates (April 29, 2022, for safety and immunogenicity and June 17, 2022, for efficacy). In the phase 2-3 trial, participants were randomly assigned (in a 2:1 ratio) to receive two 3-µg doses of BNT162b2 or placebo. On the basis of preliminary immunogenicity results, a third 3-µg dose (≥8 weeks after dose 2) was administered starting in January 2022, which coincided with the emergence of the B.1.1.529 (omicron) variant. Immune responses at 1 month after doses 2 and 3 in children 6 months to less than 2 years of age and those 2 to 4 years of age were immunologically bridged to responses after dose 2 in persons 16 to 25 years of age who received 30 µg of BNT162b2 in the pivotal trial. RESULTS: During the phase 1 dose-finding study, two doses of BNT162b2 were administered 21 days apart to 16 children 6 months to less than 2 years of age (3-µg dose) and 48 children 2 to 4 years of age (3-µg or 10-µg dose). The 3-µg dose level was selected for the phase 2-3 trial; 1178 children 6 months to less than 2 years of age and 1835 children 2 to 4 years of age received BNT162b2, and 598 and 915, respectively, received placebo. Immunobridging success criteria for the geometric mean ratio and seroresponse at 1 month after dose 3 were met in both age groups. BNT162b2 reactogenicity events were mostly mild to moderate, with no grade 4 events. Low, similar incidences of fever were reported after receipt of BNT162b2 (7% among children 6 months to <2 years of age and 5% among those 2 to 4 years of age) and placebo (6 to 7% among children 6 months to <2 years of age and 4 to 5% among those 2 to 4 years of age). The observed overall vaccine efficacy against symptomatic Covid-19 in children 6 months to 4 years of age was 73.2% (95% confidence interval, 43.8 to 87.6) from 7 days after dose 3 (on the basis of 34 cases). CONCLUSIONS: A three-dose primary series of 3-µg BNT162b2 was safe, immunogenic, and efficacious in children 6 months to 4 years of age. (Funded by BioNTech and Pfizer; ClinicalTrials.gov number, NCT04816643.).


Subject(s)
BNT162 Vaccine , COVID-19 , Adolescent , Child , Child, Preschool , Humans , Infant , Young Adult , Antibodies, Viral/blood , Antibodies, Viral/immunology , BNT162 Vaccine/administration & dosage , BNT162 Vaccine/adverse effects , BNT162 Vaccine/immunology , BNT162 Vaccine/therapeutic use , COVID-19/blood , COVID-19/immunology , COVID-19/prevention & control , COVID-19 Vaccines/administration & dosage , COVID-19 Vaccines/adverse effects , COVID-19 Vaccines/immunology , COVID-19 Vaccines/therapeutic use , Immunoglobulin G/blood , Immunoglobulin G/immunology , Vaccines/adverse effects , Vaccines/therapeutic use , Immunogenicity, Vaccine , Treatment Outcome , Vaccine Efficacy
14.
Semin Thromb Hemost ; 48(7): 769-784, 2022 Oct.
Article in English | MEDLINE | ID: covidwho-2239425

ABSTRACT

There has been a significant interest in the last decade in the use of viscoelastic tests (VETs) to determine the hemostatic competence of bleeding patients. Previously, common coagulation tests (CCTs) such as the prothrombin time (PT) and partial thromboplastin time (PTT) were used to assist in the guidance of blood component and hemostatic adjunctive therapy for these patients. However, the experience of decades of VET use in liver failure with transplantation, cardiac surgery, and trauma has now spread to obstetrical hemorrhage and congenital and acquired coagulopathies. Since CCTs measure only 5 to 10% of the lifespan of a clot, these assays have been found to be of limited use for acute surgical and medical conditions, whereby rapid results are required. However, there are medical indications for the PT/PTT that cannot be supplanted by VETs. Therefore, the choice of whether to use a CCT or a VET to guide blood component therapy or hemostatic adjunctive therapy may often require consideration of both methodologies. In this review, we provide examples of the relative indications for CCTs and VETs in monitoring hemostatic competence of bleeding patients.


Subject(s)
Blood Coagulation Disorders , Hemostatics , Humans , Thrombelastography/methods , Blood Coagulation Tests , Hemostasis , Blood Coagulation Disorders/therapy , Hemorrhage/therapy
15.
J Thorac Cardiovasc Surg ; 2022 Dec 21.
Article in English | MEDLINE | ID: covidwho-2228489

ABSTRACT

OBJECTIVE: We sought to determine the impact of right ventricular dysfunction on the outcomes of mechanically ventilated patients with COVID-19 requiring veno-venous extracorporeal membrane oxygenation. METHODS: Six academic centers conducted a retrospective analysis of mechanically ventilated patients with COVID-19 stratified by support with veno-venous extracorporeal membrane oxygenation during the first wave of the pandemic (March to August 2020). Echocardiograms performed for clinical indications were reviewed for right and left ventricular function. Baseline characteristics, hospitalization characteristics, and survival were compared. RESULTS: The cohort included 424 mechanically ventilated patients with COVID-19, 126 of whom were cannulated for veno-venous extracorporeal membrane oxygenation. Right ventricular dysfunction was observed in 38.1% of patients who received extracorporeal membrane oxygenation and 27.4% of patients who did not receive extracorporeal membrane oxygenation with an echocardiogram. Biventricular dysfunction was observed in 5.5% of patients who received extracorporeal membrane oxygenation. Baseline patient characteristics were similar in both the extracorporeal membrane oxygenation and non-extracorporeal membrane oxygenation cohorts stratified by the presence of right ventricular dysfunction. In the extracorporeal membrane oxygenation cohort, right ventricular dysfunction was associated with increased inotrope use (66.7% vs 24.4%, P < .001), bleeding complications (77.1% vs 53.8%, P = .015), and worse survival independent of left ventricular dysfunction (39.6% vs 64.1%, P = .012). There was no significant difference in days ventilated before extracorporeal membrane oxygenation, length of hospital stay, hours on extracorporeal membrane oxygenation, duration of mechanical ventilation, vasopressor use, inhaled pulmonary vasodilator use, infectious complications, clotting complications, or stroke. The cohort without extracorporeal membrane oxygenation cohort demonstrated no statistically significant differences in in-hospital outcomes. CONCLUSIONS: The presence of right ventricular dysfunction in patients with COVID-19-related acute respiratory distress syndrome supported with veno-venous extracorporeal membrane oxygenation was associated with increased in-hospital mortality. Additional studies are required to determine if mitigating right ventricular dysfunction in patients requiring veno-venous extracorporeal membrane oxygenation improves mortality.

16.
AIDS Res Hum Retroviruses ; 2022 Nov 23.
Article in English | MEDLINE | ID: covidwho-2237363

ABSTRACT

People with HIV on combination antiretroviral therapy (ART) have longer life expectancy and are increasingly experiencing age-related comorbidities. Thus, aging with HIV has become a central issue in clinical care and research, which has been particularly challenging with the intersection of the ongoing coronavirus (COVID)-19 pandemic. Since 2009, the International Workshop on HIV and Aging has served as a multidisciplinary platform to share research findings from cross-disciplinary fields along with community advocates to address critical issues in HIV and aging. In this article, we summarize the key oral presentations from the 12th Annual International Workshop on HIV and Aging, held virtually on September 23rd and 24th, 2021. The topics ranged from basic science research on biological mechanisms of aging to quality of life and delivery of care under the COVID-19 pandemic. This workshop enriched our understanding of HIV and aging under the COVID-19 pandemic, identified challenges and opportunities to combat the impact of COVID-19 on HIV communities, and also provided updated research and future directions of the field to move HIV and aging research forward, with the ultimate goal of successful aging for older people with HIV.

17.
Influenza Other Respir Viruses ; 2022 Sep 29.
Article in English | MEDLINE | ID: covidwho-2236021

ABSTRACT

BACKGROUND: Implementation of respiratory virus prevention measures requires detailed understanding of regional epidemiology; however, data from many tropical countries are sparse. We describe etiologies of ambulatory pediatric acute respiratory tract infections (ARTI) in Ecuador immediately preceding the onset of the SARS-CoV-2 pandemic. METHODS: Children < 5 years presenting to a designated study site with an ARTI were eligible. Informed consent was obtained. Demographic and clinical data were recorded. A nasopharyngeal swab was collected, processed, and analyzed using multiplex polymerase chain reaction (PCR) for common respiratory pathogens. Rhinovirus/enterovirus positive samples were further characterized by genomic sequencing. RESULTS: A total of 820 subjects were enrolled in the study between July 2018 and March 2020. A total of 655 (80%) samples identified at least one pathogen. Rhinoviruses (44%) were most common, followed by enteroviruses (17%), parainfluenza viruses (17%), respiratory syncytial virus (RSV) (15%), and influenza viruses (13%). Enterovirus D68 was the most common enterovirus detected and was among the leading causes of bronchiolitis. Seasonal RSV and influenza virus activity were different along the coast compared with the highlands. CONCLUSIONS: Ongoing regional surveillance studies are necessary to optimize available and emerging pathogen-specific preventative measures.

18.
Pain ; 2022 Jun 29.
Article in English | MEDLINE | ID: covidwho-2230689

ABSTRACT

ABSTRACT: A growing number of individuals report prolonged symptoms following acute Coronavirus-19 (COVID-19) infection, known as post-COVID-19 condition (post-COVID-19). While studies have emerged investigating the symptom sequelae of post-COVID-19, there has been limited investigation into the characterization of pain, fatigue, and function in these individuals, despite initial reports of a clinical phenotype similar to fibromyalgia syndrome (FMS) and chronic fatigue syndrome (CFS)/myalgic encephalomyelitis (ME). This study aimed to characterize multiple symptom domains in individuals reporting post-COVID-19 and compare its clinical phenotype with those with FMS and CFS. A total of 707 individuals with a single or comorbid diagnosis of post-COVID-19, FMS, and/or CFS completed multiple surveys assessing self-reported pain, fatigue, physical and cognitive function, catastrophizing, kinesiophobia, anxiety, depression, dyspnea, and sleep quality. In all 3 diagnoses, elevated pain, fatigue, anxiety, depression, catastrophizing, and kinesiophobia were reported. Physical and cognitive function were similarly impacted among individuals with post-COVID-19, FMS, and CFS; however, individuals with post-COVID-19 reported lower pain and fatigue than FMS and CFS. The comorbid diagnosis of post-COVID-19 with FMS and/or CFS further exacerbated pain, fatigue, and psychological domains when compared with post-COVID-19 alone. In summary, individuals with post-COVID-19 report a symptom phenotype similar to FMS and CFS, negatively impacting cognitive and physical function, but with less severe pain and fatigue overall. These findings may help direct future investigations of the benefit of a biopsychosocial approach to the clinical management of post-COVID-19.

19.
PNAS Nexus ; 1(2): pgac031, 2022 May.
Article in English | MEDLINE | ID: covidwho-2222694

ABSTRACT

Does information about how other people feel about COVID-19 vaccination affect immunization intentions? We conducted preregistered survey experiments in Great Britain (5,456 respondents across 3 survey waves from September 2020 to February 2021), Canada (1,315 respondents in February 2021), and the state of New Hampshire in the United States (1,315 respondents in January 2021). The experiments examine the effects of providing accurate public opinion information to people about either public support for COVID-19 vaccination (an injunctive norm) or public beliefs that the issue is contentious. Across all 3 countries, exposure to this information had minimal effects on vaccination intentions even among people who previously held inaccurate beliefs about support for COVID-19 vaccination or its perceived contentiousness. These results suggest that providing information on public opinion about COVID vaccination has limited additional effect on people's behavioral intentions when public discussion of vaccine uptake and intentions is highly salient.

20.
International Journal of Occupational Safety and Health ; 13(1):78-86, 2023.
Article in English | Scopus | ID: covidwho-2215134

ABSTRACT

Introduction: Global pandemic of COVID-19 resulted in a nationwide lockdown which affected the migrants in terms of healthcare service accessibility. This led to an increase in the prevalence of various morbidity. Objective of this study was to assess the morbidity profile of camp attendees in Bangalore urban conducted during the lockdown period of the COVID-19 pandemic. Methods: During the pandemic lockdown, health camps were conducted in selected urban under-privileged areas of Bangalore city targeting the migrant workers and these records were reviewed and relevant data were analyzed. Variables included age, gender, residential address, occupation and morbidity. Results: Among the 484 participants who had attended the medical camp, the youngest patient was 1 year old and the oldest was 75 years with a median age of 27 years (IQR: 20 – 35). The majority of the camp attendees were males (78%) and migrants (77%). Common morbidities noted were hypertension (5%) followed by musculoskeletal pain (4%). The other illnesses were anemia (3%), gastritis (2.5%), pre-diabetes (1.7%) and combined diabetes and hypertension (1.5%). There was no significant relationship between migrant status and the presence of any morbidity. Conclusion: Hypertension and musculoskeletal pain are the most common morbidity among the camp attendees. © 2023 The authors.

SELECTION OF CITATIONS
SEARCH DETAIL